WHO - World Health Organization
OBJECTIVES OF THE PROGRAMME:
First COVID-19 case was identified on 2 March 2020 in Depok, West Java. From then, the virus is rapidly spread to 489 districts in 34 provinces. As of 11 October 2020, 333 449 positive COVID-19 cases were reported, and 11 844 death cases were announced. Morbidity and mortality have affected all age groups, but mostly adults and elderly. In Indonesia, where community transmission occurs, it has majorly disrupted health and education services, and economic sectors in every level. Therefore, the Government of Indonesia plan to introduce COVID-19 vaccine as one of effective public health interventions in control communicable disease transmission and save lives.
New vaccine introduction requires quality planning and preparation, from coordination and monitoring the preparation and implementation, preparing the immunization system (i.e. vaccine procurement and distribution, waste management, data management, training of health workers), to preparation of social mobilization, communications and advocacy activities. Opportunity to improve routine immunization and preparation of upcoming Measles and Rubella (MR) campaign in 2021-2022 shall be taken advantage of.
MOH has developed roadmap of COVID-19 vaccine introduction in collaboration with inter-ministerial, ITAGI, professional organization and partners. Furthermore, WHO’s COVID-19 vaccine introduction readiness assessment tool (VIRAT) has been adopted in national technical guidance. MOH has requested WHO Indonesia’s technical assistance to finalize and conduct regular review of the road map, COVID-19 VIRAT and technical guidance. Next is to assist in monitoring during and post implementation. In addition to COVID-19 introduction, technical assistance will be also provided to prepare for potential MR SIA in 2021-2022 and to strengthen routine immunization focusing in provinces with large unvaccinated children in 2018-2020 with DPT3 as indicator and strengthening EWARS and VPD Surveillance.
Based on routine immunization and VPD surveillance indicators, as well as COVID-19 transmission, identified provinces are Aceh, North Sumatera, Riau, West Java, East Java, Central Java, South Kalimantan, West Sumatera, Lampung, East Nusa Tenggara, West Kalimantan, DKI Jakarta, Banten, South East Sulawesi, Maluku, Central Kalimantan, West Sulawesi, Gorontalo, North Kalimantan and Central Sulawesi. Selected candidate is expected to engage with Ministry of Health, national and sub-national stakeholders and partners to provide high quality TA/coordination as per Term of Reference (TOR).
SUMMARY OF ASSIGNED DUTIES:
Under the overall guidance and supervision of the WHO Representative to Indonesia (WR) and the direct supervision of the Medical Officer EPI, the consultant will support sub national (provinces and Districts) in planning, preparation, coordination, training, logistics, monitoring and assessment for the COVID-19 vaccine introduction, routine immunization, MR campaign, VPD Surveillance and EWARS in selected provinces and districts; this will include
- Coordinating and monitoring the preparation and implementation of COVID-19 vaccine introduction and MR campaign, including facilitating communication between local provincial partners
- Technical assistance in implementing capacity building of health worker (i.e training and orientation) of health staff
- Support advocacy with relevant stakeholders (e.g. Task Force, Coordinating Ministry of Economic Affair, Ministry of Religious Affairs, Ministry of Education, Religious Organization, etc) for COVID-19 vaccination, RI, MR SIA, VPD, EWARS, COVID-19 and AEFI surveillance
- Technical assistance to province and districts to implement utilizing COVID-19 VIRAT, strengthen routine immunization (RI), specifically, defaulter tracking tool and MR SIA as an opportunity for identification of defaulters and ensure proper follow up
- Strengthen RI micro plans at HC using RED strategy and updating high risk areas, mapping, monitoring of communication plan and cold chain management.
- Coordinate with relevant partners and stakeholder to strengthen risk communication strategy, including training, monitoring and supervision
- Strengthening data analysis to track low performance immunization area, including follow up of dashboard monitoring, and provide regular feedback (e.g. bulletin)
- Monitoring COVID-19, MR SIA and routine immunization session to ensure it is following national guidance, particularly in implementing COVID-19 prevention measures
- Providing regular feedback to the MOH, PHO, DHO and the WHO team; and
- Any other activities assigned by WHO Representative, and
- Submit a detail final report at the end of the assignment
EDUCATIONAL QUALIFICATIONS, EXPERIENCE, ETC.
- Respecting and promoting individual and cultural differences
- Producing results
- Knowing and managing yourself
Functional Knowledge and Skills:
Understanding of data entry, data analysis and producing reports
Master’s degree in a health-related subject from a recognized institution
PHD in relevant field
At least two years’ experience in public health program implementation preferably in Immunization, Communicable Diseases, VPD surveillance and EWARS
At least four years’ experience in public health program implementation, preferably in Immunization, Communicable Diseases, VPD surveillance and EWARS; ability to deliver public health training, using techniques of mentoring and on-the-job training; management/supervision of public health program at the province and district level
Fluent in English and Bahasa Indonesia
Other Skills (e.g. IT):
Work is performed in normal working environment.
Computer literacy: Working knowledge on Ms. Word, Ms. Excel and Ms. Power Point
Vacancy Notice (SSA): Vaccination Technical Officer COVID-19. In accordance with WHO Salary Scale for SSA in Indonesia (Level A: 25,708,600 – 41,419,266 IDR).
*Candidates who have already applied for VN 2004320, VN 2100632 and VN 2102378 of SSA Vaccination Technical Officer COVID-19 Level A, do not need to reapply.
For information on WHO’s operations please visit: http://www.searo.who.int/indonesia
LATE APPLICATIONS WILL NOT BE ACCEPTED
- A written test may be used as a form of screening for the short-listed applicants. The performance in written test will decide on applicant’s eligibility to appear in the interview.
- Only candidates under serious consideration will be contacted.
- WHO is committed to workforce diversity.
- WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
To help us track our recruitment effort, please indicate in your cover/motivation letter where (unjobvacancies.com) you saw this job posting.